中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 35 Issue 10
Oct.  2019
Turn off MathJax
Article Contents

The development history of new biomarkers for hepatitis B virus infection

DOI: 10.3969/j.issn.1001-5256.2019.10.001
  • Received Date: 2019-09-10
  • Published Date: 2019-10-20
  • The objective of antiviral therapy for chronic hepatitis B is to maximize the long-term inhibition of hepatitis B virus(HBV) replication,reduce hepatocyte inflammation and liver fibrosis,and delay and reduce liver failure,decompensated cirrhosis,hepatocellular carcinoma,and other complications. In addition to serum HBV DNA which has been used for a long time,new biomarkers such as intrahepatic HBV cccDNA,serum HBcrAg,serum HBV RNA,serum HBsAg,and serum anti-HBc are commonly used in recent years to evaluate antiviral response in clinical practice,and their clinical value has attracted more and more attention. Such biomarkers have important clinical significance in monitoring and evaluating antiviral response and predicting the risk of viral rebound after drug withdrawal and the risk of hepatocellular carcinoma.

     

  • loading
  • [1] ZHONG Y,HAN J,ZOU Z,et al. Quantitation of HBV covalently closed circular DNA in micro formalin fixed paraffin-embedded liver tissue using rolling circle amplification in combination with real-time PCR[J]. Clin Chim Acta,2011,412(21-22):1905-1911.
    [2] ZHONG Y,HU S,XU C,et al. A novel method for detection of HBVcccDNA in hepatocytes using rolling circle amplification combined with in situ PCR[J]. BMC Infect Dis,2014,14:608.
    [3] WANG J,SHEN T,HUANG X,et al. Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound[J]. J Hepatol,2016,65(4):700-710.
    [4] WANG J,SHENG Q,DING Y,et al. HBV RNA virion-like particles produced under nucleos(t)ide analogues treatment are mainly replication-deficient[J]. J Hepatol,2018,68(4):847-849.
    [5] CORNBERG M,WONG VW,LOCARNINI S,et al. The role of quantitative hepatitis B surface antigen revisited[J]. J Hepatol,2017,66(2):398-411.
    [6] CHEN J,ZHANG DH,XU CR,et al. Quantitative hepatitis B surface antigen combined with hepatitis B e antigen as sustained virological response predictors during extended therapy with Peginterferon alfa-2a for hepatitis B e antigen-positive chronic hepatitis B[J]. J Clin Virol,2015,72:88-94.
    [7] YU DM,LI XH,MOM V,et al. N-glycosylation mutations within hepatitis B virus surface major hydrophilic region contribute mostly to immune escape[J]. J Hepatol,2014,60(3):515-522.
    [8] SONG LW,LIU PG,LIU CJ,et al. Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection[J]. Clin Microbiol Infect,2015,21(2):197-203.
    [9] FAN R,SUN J,YUAN Q,et al. Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBe Ag seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues[J]. Gut,2016,65(2):313-320.
    [10] MAK LY,WONG DK,CHEUNG KS,et al. Review article:Hepatitis B core-related antigen(HBcrAg):An emerging marker for chronic hepatitis B virus infection[J]. Aliment Pharmacol Ther,2018,47(1):43-54.
    [11] CHEN EQ,FENG S,WANG ML,et al. Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis B[J].Sci Rep,2017,7(1):173.
    [12] CHEN EQ,WANG ML,TAO YC,et al. Serum HBcrAg is better than HBV RNA and HBs Ag in reflecting intrahepatic covalently closed circular DNA[J]. J Viral Hepat,2019,26(5):586-595.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1410) PDF downloads(578) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return